Targeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial)
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 47
Summary
- Conditions
- Prostate Cancer
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: Non-RandomizedIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Only males
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03787680
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Zachery Reichert, M.D. University of Michigan Rogel Cancer Center
Get Well Soon